Analytical performance evaluation of the new double-antibody sandwich Mindray total vitamin D assay and comparison vs. liquid chromatography tandem mass spectrometry

Abstract Objectives Measurement of total 25-hydroxyvitamin-D [25(OH)D] is widely used to assess vitamin D status, but immunoassays may show method-dependent differences related to calibration, analyte recognition, and metabolite effects. The new Mindray 25(OH)D assay is a noncompetitive chemiluminescent immunoassay based on an anti-metatype antibody design. Methods We evaluated calibration stability, precision, linearity, recovery, limit of quantification (LoQ), and potential effects of 24,25(OH)2D3, C3-epi-25(OH)D3 and 25(OH)D2. Serum and K 3 -EDTA plasma were compared in 150 paired samples. Comparison with a VDSP-certified LC-MS/MS was assessed in 146 serum samples. A regression derived recalibration equation was subsequently evaluated in an independent cohort of 115 samples. Results Total coefficients of variation (CVs) were 2.05–5.69 % across concentrations. Calibration remained within the predefined acceptance criteria for 31 days. The assay was linear from 3.92 to 136 μg/L (R 2 =0.9998), and the LoQ was 2.78 μg/L (CV=3.65 %). Mean recovery across 33 mixtures was 101.31 % (95 % CI, 100.47–102.15 %), with results ranging from 96.14 to 105.12 %. No clinically relevant effects of the investigated vitamin D metabolites were observed within the studied ranges. Serum and EDTA-plasma results were highly concordant. The CCC of the immunoassay vs. LC-MS/MS was 0.940, with a mean Bland–Altman difference of −2.5451 μg/L; after recalibration in the independent cohort, CCC increased to 0.995 and the mean difference was +0.0045 μg/L. Conclusions The Mindray assay showed excellent analytical performance over the evaluated range and matrices. Its initial difference from the LC-MS/MS method was reduced after regression recalibration. The findings emphasize the importance of reference-procedure alignment and verification of method bias at clinically relevant concentrations.

Authors

Institutions

Publication Details

Journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2026-11-16
DOI
https://doi.org/10.1515/cclm-2026-1593
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Analytical performance evaluation of the new double-antibody sandwich Mindray total vitamin D assay and comparison vs. liquid chromatography tandem mass spectrometry

Pierre Lukas, Konstantinos Makris, Efstathios Chronopoulos, Ioulia Trifonidi et al.
1 links
Clinical Chemistry and Laboratory Medicine (CCLM)
Vitamin D Research Studies
article

Analytical performance evaluation of the new double-antibody sandwich Mindray total vitamin D assay and comparison vs. liquid chromatography tandem mass spectrometry

Pierre Lukas, Konstantinos Makris, Efstathios Chronopoulos, Ioulia Trifonidi, Etienne Cavalier
article en

Abstract

Abstract Objectives Measurement of total 25-hydroxyvitamin-D [25(OH)D] is widely used to assess vitamin D status, but immunoassays may show method-dependent differences related to calibration, analyte recognition, and metabolite effects. The new Mindray 25(OH)D assay is a noncompetitive chemiluminescent immunoassay based on an anti-metatype antibody design. Methods We evaluated calibration stability, precision, linearity, recovery, limit of quantification (LoQ), and potential effects of 24,25(OH)2D3, C3-epi-25(OH)D3 and 25(OH)D2. Serum and K 3 -EDTA plasma were compared in 150 paired samples. Comparison with a VDSP-certified LC-MS/MS was assessed in 146 serum samples. A regression derived recalibration equation was subsequently evaluated in an independent cohort of 115 samples. Results Total coefficients of variation (CVs) were 2.05–5.69 % across concentrations. Calibration remained within the predefined acceptance criteria for 31 days. The assay was linear from 3.92 to 136 μg/L (R 2 =0.9998), and the LoQ was 2.78 μg/L (CV=3.65 %). Mean recovery across 33 mixtures was 101.31 % (95 % CI, 100.47–102.15 %), with results ranging from 96.14 to 105.12 %. No clinically relevant effects of the investigated vitamin D metabolites were observed within the studied ranges. Serum and EDTA-plasma results were highly concordant. The CCC of the immunoassay vs. LC-MS/MS was 0.940, with a mean Bland–Altman difference of −2.5451 μg/L; after recalibration in the independent cohort, CCC increased to 0.995 and the mean difference was +0.0045 μg/L. Conclusions The Mindray assay showed excellent analytical performance over the evaluated range and matrices. Its initial difference from the LC-MS/MS method was reduced after regression recalibration. The findings emphasize the importance of reference-procedure alignment and verification of method bias at clinically relevant concentrations.

Clinical Chemistry and Laboratory Medicine (CCLM)
University of Liège (BE), National and Kapodistrian University of Athens (GR), KAT General Hospital of Attica (GR)
Good health and well-being
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon